Key statistics
On Friday, Citius Pharmaceuticals Inc (CTXR:NAQ) closed at 0.4115, 32.74% above the 52 week low of 0.31 set on Nov 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.417 |
---|---|
High | 0.441 |
Low | 0.3949 |
Bid | 0.41 |
Offer | 0.42 |
Previous close | 0.3822 |
Average volume | 968.36k |
---|---|
Shares outstanding | 180.73m |
Free float | 168.42m |
P/E (TTM) | -- |
Market cap | 74.37m USD |
EPS (TTM) | -0.2443 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR™ (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
- Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 Financial Results and Provides Business Update
- Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.
- Citius Pharmaceuticals to Host Investor Call to Discuss Recent and Upcoming Developments
More ▼